Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Rating) CEO Todd Harris sold 12,773 shares of the stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $16.13, for a total value of $206,028.49. Following the sale, the chief executive officer now owns 1,701,276 shares of the company’s […]
Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Rating) CEO Todd Harris sold 7,927 shares of the company’s stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $16.00, for a total transaction of $126,832.00. Following the completion of the transaction, the chief executive officer now owns 1,701,276 shares of […]
Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Rating) CEO Todd Harris sold 7,927 shares of the stock in a transaction that occurred on Tuesday, June 13th. The shares were sold at an average price of $16.00, for a total transaction of $126,832.00. Following the sale, the chief executive officer now owns 1,701,276 shares in the company, […]
Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Rating)’s stock price rose 7.7% during trading on Monday . The company traded as high as $15.95 and last traded at $15.95. Approximately 6,475 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 41,091 shares. The stock had previously closed at $14.81. […]
Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Rating) were up 9.2% during mid-day trading on Tuesday . The company traded as high as $15.60 and last traded at $14.94. Approximately 16,658 shares changed hands during trading, a decline of 59% from the average daily volume of 41,004 shares. The stock had previously closed at […]